Outcome of noncatheter-related thrombosis in children: Influence of underlying or coexisting factors

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 3, 2001, Pages 159-164

  Gurgey, Aytemiz ^a   Aslan, Deniz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid antibodies; Antithrombin III; Catheter; Factor V leiden; Protein C; Protein S; Prothrombin 20210A; Thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ARTICLE; CATHETERIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HUMANS; INFANT; MALE; PROTEIN C; PROTEIN S; THROMBOSIS;

EID: 0035055063     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200103000-00007     Document Type: Article

References (22)

1. Andrew M, David M, Adams M, et al. Venous thromboembolic complications in children: first analyses of the Canadian registry of VTE. Blood 1994; 83:1251-7.
2. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995; 96:291-4.
3. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter-related thrombosis in children: analysis of the Canadian Registry of venous thromboembolic complications. J Pediatr 1998; 133:770-6.
4. Gürgey A. Clinical manifestations in thrombotic children with factor V Leiden mutation. Pediatr Hematol Oncol 1999; 16:1-5.
5. Hagstrom JN, Walter J, Bluebond-Langner R, et al. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998; 133:777-81.
6. Nowak-Gottl U, Strater R, Dubbers A, et al. Ischaemic stroke in infancy and childhood: role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 1996; 7:684-8.
7. Junker R, Koch HG, Auberger K, et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999: 19;2568-72.
8. Uttenreuter-Fischer MM, Vetter B, Hellmann C, et al. Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997; 156:277-81.
9. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999: 81;176-8.
10. Nowak-Göttl U, Koch HG, Aschka J, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996; 92:992-8.
11. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-7.
12. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-703.
13. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two-year survey. Arch Dis Child 1997; 76:F173.
14. Streif W, Andrew M. Venous thromboembolic events in pediatric patients. Hematol Oncol Clin North Am 1998; 12:1284.
15. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997; 39:313-5.
16. Gurgey A, Hicsonmez G, Parlak H, et al. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol 1998; 59:179-80.
17. Smith OP, White B. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 1999: 104;202-7.
18. Brandtzaeg P, Sandset M, Joo GB, et al. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic coagulation pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55:459-70.
19. Kirchhofer D, Riederer MA, Baumgartner HR. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 1997; 89:1270-8.
20. Bonduel M, Hepner M, Sciuccati G, et al. Infectious purpura fulminans in children. Intl J Pediatr Hematol Oncol 1998; 5:21-7.
21. Powars DR, Rogers ZR, Patch MJ, et al. Purpura fulminans in meningococcemia: association with acquired deficiencies of protein C and S. N Engl J Med 1987; 317:571-4.
22. Taylor FB Jr, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of E. coli infusion in the baboon. J Clin Invest 1987; 79:918-25.